Last C$0.25 CAD
Change Today +0.005 / 2.08%
Volume 18.0K
As of 10:03 AM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

critical outcome technologie (COT) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/17/14 - C$0.37
52 Week Low
04/29/14 - C$0.14
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

critical outcome technologie (COT) Related Businessweek News

No Related Businessweek News Found

critical outcome technologie (COT) Details

Critical Outcome Technologies Inc., a bioinformatics company, is engaged in the discovery and development of small molecules. The company focuses on applying CHEMSAS, a proprietary computer based technology, which identifies, profiles, optimizes, selects, and validates commercially viable drug candidates at the discovery stage of preclinical drug development. It focuses on developing drug candidates for the treatment of various cancers, such as acute myelogenous leukemia, small cell lung, ovarian, endometrial, pancreatic, brain, breast, and colorectal cancers, as well as HIV, multiple sclerosis, Alzheimer’s disease, and methicillin-resistant staphylococcus aureus. Its lead oncology compound is COTI-2, a molecule in Phase I clinical trial. The company is also engaged in the development of Rosalind, which provides personalized oncology drug treatment recommendations to physicians and patients based on the genetic profile of each individual patient’s specific cancer. Critical Outcome Technologies Inc. is headquartered in London, Canada.

6 Employees
Last Reported Date: 07/24/14

critical outcome technologie (COT) Top Compensated Officers

Co-Founder, Chief Executive Officer, Presiden...
Total Annual Compensation: C$170.0K
Chief Financial Officer
Total Annual Compensation: C$130.0K
Compensation as of Fiscal Year 2014.

critical outcome technologie (COT) Key Developments

Critical Outcome Technologies Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 04:00 PM

Critical Outcome Technologies Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-14-2015 04:00 PM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Critical Outcome Technologies Inc. Reports Financial Results for the Second Quarter and Six Months Ended October 31, 2014

Critical Outcome Technologies Inc. reported financial results for the second quarter and six months ended October 31, 2014. The company's operational activities during the quarter were focused in three main areas; first, the completion of testing and preparation of the IND submission for COTI-2; second, financing efforts to fund the Phase 1 human trial of COTI-2 and the Company's operations for the next year; and, third, business development initiatives. These activities resulted in the Company incurring a net loss of $946,204, or $0.01 per share, for the quarter compared to a net loss of $598,220, or $0.01 per share, for the second quarter a year earlier. For the six months ended October 31, 2014, the Company reported a loss of $1,917,000 or $0.02 per common share, compared to a loss of $1,098,273, or $0.01 per common share, for the same period last year. The increased loss for the quarter and year-to-date were attributable to increased expenses of $325,507 and $776,726 respectively in all functional expense areas but primarily research and development and general and administration.

Critical Outcome Technologies Inc. to Report First Half, 2015 Results on Nov 28, 2014

Critical Outcome Technologies Inc. announced that they will report first half, 2015 results on Nov 28, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COT:CN C$0.25 CAD +0.005

COT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for COT.
View Industry Companies

Industry Analysis


Industry Average

Valuation COT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 13.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CRITICAL OUTCOME TECHNOLOGIE, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at